RPRX

NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$58.41

-0.52 (-0.88%)

As of Sep 20, 9:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target -37.9% upside

Low Target $26.65

Average Target $36.26

High Target $40.53

Current Price $58.41

Current
$58.41

Target
$36.26

$26.65 $36.26 avg $40.53

Scenario Analysis

Bear Case

$26.65

-54.4%

Low target

Base Case

$36.26

-37.9%

Avg target

Bull Case

$40.53

+-30.6%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$64.38

-9.3% from high

52-Week Low

$34.63

+68.7% from low

50-Day SMA

$40.77

+43.3% vs SMA

200-Day SMA

$37.28

+56.7% vs SMA

RSI (14)

85.1

Overbought

Target vs 52W High

$36.26

-43.7% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.4%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+10.9%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.6%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+176.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.9%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.9%